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In the next half decade, the split in demand for CaAs substrates between device companies and epiwafer sup- 
pliers will only widen. Device makers have products based on MESFET devices, which are largely implant-based. 
Newer devices are virtually all based on epitaxy. The demand for the newer devices is increasing at a faster rate 
than that for MESFETs. Thus the demand for epiwafers is set to increase more strongly over the next five years. 
S 
o too, demand for epitaxy- 
ready SI GaAs substrates is al- 
so increasing. The end 
customer is the device maker but 
at present the business is split be- 
tween merchant epiwafer supply 
and production of epiwafers by 
the device makers themselves. The 
ratio of captive to merchant is 
changing and the demand for epi- 
wafers is increasing from both. 
Substrate demand is therefore also 
increasing but much in this sector 
remains the same, especially where 
procedures are concerned. 
Criteria for substrate selection 
differ somewhat for captive and 
merchant supply even though, to a 
large extent, the products are the 
same from the substrate maker’s 
viewpoint. It is likely that for some 
customers, such as opto suppliers 
and PHEMT suppliers, substrate in- 
spection is more abbreviated but 
in order to do this they must have 
a close working relationship with a 
few key substrate suppliers After 
all, the last thing you want is a re- 
jection of an expensive epiwafer 
due to a problem with a relatively 
inexpensive substrate. 
LEC versus VCF 
and VB? 
In the next five years some of the 
most important trends will be in 
this area. One of these is in the 
choice of substrates: LEC is well-es- 
tablished but VGF or VB undoped 
material is taking market share. 
Implant is still very much the ma- 
jor user of annealed LEC material 
and many people are looking at 
VGE Benefits have yet to become 
clear, however, with some users 
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reporting less success with the 
newer material. 
Interestingly, better reliability 
has been seen for epi-based HBTs 
grown on VGF or VB over those 
grown on LEC. VGF has seen most 
success in opto and could therefore 
repeat this success in the epi world. 
Many LEC-oriented suppliers - es- 
pecially the non-US ones, have had 
to play catch-up with VB and VGF 
undoped material. The jury is out 
over the technical significance of 
this increased reliability - especially 
since the average life of a mobile 
phone is currently under a year! 
There are signs that the business 
is shifting more towards merchant 
epiwafer supply - and consequent- 
ly away from captive. This has im- 
portant ramifications for the future 
substrate supply business. While 
substrate specifications do not dif- 
fer that much, purchasing criteria 
certainly do. The traditional ap- 
proach for device makers has led to 
companies being locked in with 
favoured substrate suppliers. As the 
device technology moves further 
on to epitaxy-based materials, less 
direct substrate supply will be im- 
portant. This will weaken the rela- 
tionship between the substrate 
supplier and the device maker. 
There is a possibility that device 
suppliers could capitalize on this 
change. There is an industry-wide 
trend to ‘shorten the lines of sup- 
ply’ and this could encourage a 
change in the substrate business. 
Substrate vendors already do a lot of 
business with epiwafer companies. 
This business is likely to increase at 
a stronger rate than the implant 
wafer business. This is a crucial 
point. Implant has always been 
captive whereas epitaxy has devel- 
oped into a standalone business. 
Entry opportunities 
There is another factor within the 
shift from captive to merchant. 
Today’s industry has no entry point 
for new suppliers of substrates. 
Device companies prefer to use just 
a few suppliers of substrates.There is 
little opportunity for any new en- 
trant to become ‘qualified’. Unless a 
major supplier exits the business, the 
status quo looks set to remain indeB- 
nitely. However, the shift away from 
implant to epitaxy-based devices will 
change this business set-up. 
In future a device company may 
cease its direct dealings with sub- 
strate suppliers completely It will 
buy epiwafers instead. In turn, the 
epiwafer supplier will source its 
substrates needs from the existing 
cadre of suppliers. But here lies the 
opportunity for a new substrate 
manufacturer to start up business. 
It would achieve this by one of sev- 
eral routes. For instance via a deal 
with an epiwafer company. A new 
entrant who can make the right of- 
fer and guarantee delivery may suc- 
ceed where in the past it would 
have failed. Or we may see an epi- 
wafer supplier acquire a substrate 
company or vice-versa. Both of 
these scenarios run contrary to 
prevailing trends. 
Of these possible scenarios, the 
notion of a new entrant is the more 
likely The point here is that previ- 
ously it was almost impossible to 
contemplate a new entrant in this 
business sectotwith the shift in the 
business more towards epitaxy, a 
window of opportunity has opened. 
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